Selected article for: "control group and real time"

Author: Abdelhafiz, Ahmed S.; Fouad, Mariam A.; Sayed-Ahmed, Mohamed M.; Kamel, Mahmoud M.; Ali, Asmaa; Fouda, Merhan; Khalil, Mahmoud A.; Abdel-Moneim, Ahmed S.; Kamal, Lamyaa M.
Title: Upregulation of FOXP3 is associated with severity of hypoxia and poor outcomes in COVID-19 patients
  • Cord-id: 47uk6f5p
  • Document date: 2021_8_28
  • ID: 47uk6f5p
    Snippet: The levels of messenger RNA (mRNA) transcription of FOXP3, IFN-γ, TNF, IL-6 and COX-2 from both COVID-19 infected and control subjects were evaluated using SYBR(TM) green real-time polymerase chain reaction (RT-PCR). Severe/critical cases showed significantly lower lymphocyte counts and higher neutrophil counts than the mild or moderate cases. There were significantly lower levels of mRNA expressions of IFN-γ, TNFα and FOXP3 in COVID-19 patients than in the control group. On the other hand, I
    Document: The levels of messenger RNA (mRNA) transcription of FOXP3, IFN-γ, TNF, IL-6 and COX-2 from both COVID-19 infected and control subjects were evaluated using SYBR(TM) green real-time polymerase chain reaction (RT-PCR). Severe/critical cases showed significantly lower lymphocyte counts and higher neutrophil counts than the mild or moderate cases. There were significantly lower levels of mRNA expressions of IFN-γ, TNFα and FOXP3 in COVID-19 patients than in the control group. On the other hand, IL-6 and COX-2 expressions were significantly higher in patients suffering from severe disease. FOXP3 expressions were correlated with the severities of hypoxia and were excellent in predicting the disease severity. This was followed by the IL-6, COX-2 and TNFα expressions. FOXP3 expression was the only biomarker to show a significant correlation with patient mortality. It was concluded that SARS-CoV-2 infection is associated with the downregulation of FOXP3 and upregulations of IL-6 and COX-2.

    Search related documents:
    Co phrase search for related documents
    • acetic acid and lung injury: 1
    • acetic acid and lung tissue: 1
    • acute ards respiratory distress syndrome and adaptive immunity: 1, 2, 3, 4, 5, 6, 7
    • acute ards respiratory distress syndrome and lung injury: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute ards respiratory distress syndrome and lung tissue: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute ards respiratory distress syndrome and lymphocyte count: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute ards respiratory distress syndrome and lymphocyte neutrophil: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute ards respiratory distress syndrome and lymphocyte neutrophil macrophage: 1
    • acute lung injury and adaptive immunity: 1, 2, 3, 4, 5, 6
    • acute lung injury and lung injury: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute lung injury and lung tissue: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute lung injury and lymphocyte count: 1, 2, 3
    • acute lung injury and lymphocyte neutrophil: 1, 2, 3, 4, 5
    • adaptive immunity and lung injury: 1, 2, 3, 4, 5, 6, 7
    • adaptive immunity and lung tissue: 1, 2, 3, 4, 5, 6, 7
    • adaptive immunity and lymphocyte count: 1, 2, 3, 4, 5
    • adaptive immunity and lymphocyte neutrophil: 1, 2, 3, 4, 5, 6, 7, 8
    • lung injury and lymphocyte count: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • lung injury and lymphocyte neutrophil: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11